South Dakota Investment Council’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,082
Closed -$2.67M 599
2021
Q4
$2.67M Sell
7,082
-360
-5% -$140K 0.04% 303
2021
Q3
$3.07M Sell
7,442
-5,200
-41% -$2.16M 0.06% 271
2021
Q2
$4.68M Sell
12,642
-20
-0.2% -$6.68K 0.08% 215
2021
Q1
$3.67M Buy
12,662
+1,212
+11% +$337K 0.06% 259
2020
Q4
$2.86M Hold
11,450
0.05% 280
2020
Q3
$2.59M Hold
11,450
0.06% 259
2020
Q2
$2M Buy
11,450
+1,000
+10% +$160K 0.05% 297
2020
Q1
$1.32M Buy
10,450
+990
+10% +$148K 0.04% 329
2019
Q4
$1.45M Sell
9,460
-970
-9% -$134K 0.03% 370
2019
Q3
$1.38M Buy
10,430
+3,330
+47% +$446K 0.03% 405
2019
Q2
$1.01M Hold
7,100
0.02% 417
2019
Q1
$1.03M Buy
7,100
+1,000
+16% +$131K 0.02% 419
2018
Q4
$690K Hold
6,100
0.02% 436
2018
Q3
$821K Buy
+6,100
New +$753K 0.02% 445

Other funds holding CRL

South Dakota Investment Council's CRL Position: Q1 2022 in Review

South Dakota Investment Council sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 7,082 shares — an estimated $2.67M sold.

South Dakota Investment Council first reported a position in CRL in Q3 2018 and held it in 14 quarters. The position peaked at $4.68M in Q2 2021. 645 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • South Dakota Investment Council reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • South Dakota Investment Council sold 7,082 Charles River Laboratories shares in Q1 2022, an estimated $2.67M.
  • South Dakota Investment Council first reported a position in Charles River Laboratories in Q3 2018 and held it in 14 quarters.
  • South Dakota Investment Council's Charles River Laboratories position peaked at $4.68M in Q2 2021.
  • 645 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on South Dakota Investment Council's 13F filing for Q1 2022, filed 10 May 2022.